CN Patent
CN113943329A — 一种坎格列净中间体的非对映异构体的制备方法
Assigned to SYNCOZYMES (SHANGHAI) CO Ltd · Expires 2022-01-18 · 4y expired
What this patent protects
本发明公开了一种坎格列净中间体(化合物II)的非对映异构体(化合物I)的制备方法。本发明的方法为化合物II在Lewis酸与硼氢化锂的催化作用下生成化合物I。本发明的方法,原料易获得,反应条件温和,操作简单。
USPTO Abstract
本发明公开了一种坎格列净中间体(化合物II)的非对映异构体(化合物I)的制备方法。本发明的方法为化合物II在Lewis酸与硼氢化锂的催化作用下生成化合物I。本发明的方法,原料易获得,反应条件温和,操作简单。
Drugs covered by this patent
- Invokana (CANAGLIFLOZIN) · Johnson & Johnson
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.